Xingshan Cai Selected Research

Xingshan Cai Research Topics

4	Tuberculosis (Tuberculoses) 07/2020 - 01/2012
2	Pulmonary Tuberculosis 11/2022 - 12/2014
1	Extensively Drug-Resistant Tuberculosis 01/2020
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Inflammation (Inflammations) 01/2019

3	Rifampin (Rifampicin)FDA LinkGeneric 11/2022 - 01/2012
2	Streptomycin (Streptomycin Sulfate)FDA Link 07/2020 - 01/2012
2	Amikacin (A.M.K)FDA LinkGeneric 07/2020 - 01/2020
2	Isoniazid (Ftivazide)FDA LinkGeneric 12/2014 - 01/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2020
1	mycolactoneIBA 01/2019
1	Pyrazinamide FDA LinkGeneric 01/2017
1	Therapeutic UsesIBA 12/2014
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2012
1	Rifabutin (Ansamycin)FDA Link 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	Codon (Codons)IBA 01/2012

1	Injections 01/2020